A short list, not 10,000 names
Start from operating companies and apply region, sector, liquidity and freshness before reading anything.
Discover · every morning
Every morning the whole market is scored and ranked. You pick a point of view — a thesis — and a few clean names rise to the top, with something you rarely get to see: how often a name has shown up before, and whether it's new or coming back.
A triage layer for research — not a buy/sell signal or a recommendation.
How it looks
Switch the point of view and the list re-ranks; the counter falls from the universe to a short list.
12
10.742
names scanned
worth a look
Live recreation. The video walkthrough is coming soon.
Discover
It's the first review layer, not the decision layer.
Start from operating companies and apply region, sector, liquidity and freshness before reading anything.
Ready-made views (compression, early ignition, quality pullback, re-rating, repair, confirmation) or your own.
It tells you how often a name has surfaced and whether it's new or returning — something almost no one shows.
Freshness, data notices and caveats travel with the candidate instead of being hidden.
When a name deserves more, you open its full read — evidence, context and events.
It prioritises what to review; the evidence and the judgement stay yours.
In development
Track record for each point of view — how it has behaved over time.
New points of view, e.g. for explosive micro-cap moves.
No dates — we ship each piece once it's measured and its limits are clear.
Why the list holds up
It organises evidence and priority; it never turns candidates into recommendations.
Operating universe
7,527 operating companies remain after filtering out anything that isn't an operating company.
10 exchanges
US and Europe: NYSE, NASDAQ, London, Frankfurt, Paris, Amsterdam, Brussels, Lisbon, Zurich, Madrid.
Left out, on purpose
Funds, ETFs and similar vehicles stay out so the focus is operating companies.
You stay in the loop
It can prioritise evidence, but it never becomes an order or a trade instruction.
Whenever you like
Ask for access to the private beta, or sign in if you already have an account. The decision stays yours — we bring the evidence.
Payments aren't active yet. The beta stays invite-only while access is controlled.
Research, not advice
HornScout is a research and analytics product. It does not provide personalized advice or trade signals. Patterns and historical context inform decisions; they do not replace your own judgment.